Boston Scientific Corporation
Boston Scientific Reports Strong Q4 and FY 2023 Results, Exceeds Guidance
Summary
Boston Scientific Corporation announced robust financial results for Q4 and FY 2023, with net sales increasing by 14.9% and 12.3% respectively, surpassing its guidance. The company reported GAAP net income of $0.34 per share for Q4 and $1.07 per share for FY 2023, and adjusted EPS of $0.55 for Q4 and $2.05 for FY 2023. The strong performance was driven by significant growth across all segments and regions. The company also announced FDA approvals, clinical trial commencements, and acquisitions, enhancing its product portfolio and market presence.
Profitelligence Alerts
Get alerts for BSX
Be first to know when Boston Scientific Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Boston Scientific Corporation
Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.
Official SEC Documents
Advertisement